Because L-alanosine can completely abrogate AMP supply in MTAP-deficient cells, we investigated whether L-alanosine can effectively inhibit this aggressive subset of myxofibrosarcomas by targeting the methionine de novo pathway [13]. The gene discussed is MTAP; the disease is myxofibrosarcoma.